Aquarius Surgical Technologies Inc
CNSX:ASTI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/FCFF
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Valuation Scenarios
If EV/FCFF returns to its Industry Average (11.5), the stock would be worth CA$-0 (129% downside from current price).
| Scenario | EV/FCFF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -39.3 | CA$0.01 |
0%
|
| Industry Average | 11.5 | CA$-0 |
-129%
|
| Country Average | 20.4 | CA$-0.01 |
-152%
|
Forward EV/FCFF
Today’s price vs future free cash flow to firm
Peer Comparison
| Market Cap | EV/FCFF | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
A
|
Aquarius Surgical Technologies Inc
CNSX:ASTI
|
276k CAD | -39.3 | -0.2 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
285.7B USD | 0 | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | -103 746.2 | 4 020.7 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
99.6B ZAR | 19.4 | 10.3 | |
| US |
F
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
67.4B USD | -45 536 | 38 074.9 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
57.3B USD | 0 | 0 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
37.3B CHF | 0 | 0 | |
| US |
|
Coupang Inc
F:788
|
31.3B EUR | 60.1 | 173.5 | |
| US |
|
Symbotic Inc
NASDAQ:SYM
|
34.5B USD | 43.2 | -3 268.5 | |
| US |
Q
|
Qnity Electronics Inc
NYSE:Q
|
29.6B USD | 0 | 0 |
Market Distribution
| Min | 0 |
| 30th Percentile | 13.1 |
| Median | 20.4 |
| 70th Percentile | 33.5 |
| Max | 22 577.3 |
Other Multiples
Aquarius Surgical Technologies Inc
Glance View
Aquarius Surgical Technologies, Inc. engages in the provision of innovative, minimally invasive medical laser systems, and consumables for multiple medical disciplines, principally in the field of urology. The company is headquartered in Halifax, Nova Scotia. The Company, through its subsidiary Surgical Lasers Inc, primarily focuses on the development, sales, distribution, marketing, and exploitation of non-invasive surgical technologies using lasers. The firm provides integrated laser-based solutions across multiple medical disciplines. These disciplines include urology, gynecology, ophthalmology, thoracic, ears, nose, and throat (ENT), cardiovascular, and neurosurgery. The firm's laser solutions comprise technology, support, consumables, and education.
